MaxQ AI
About MaxQ AI
MaxQ AI, formerly known as MedyMatch Technology, was a healthcare artificial intelligence company dedicated to enhancing clinical decision support for physicians, particularly in acute care settings. The company’s flagship offering was the Accipio platform, which leveraged deep learning and machine vision to analyze non-contrast head CT images. This technology was designed to identify and prioritize suspected acute intracranial hemorrhage (ICH), stroke, and traumatic brain injury, aiming to enable faster, more accurate diagnoses and improve patient triage and workflow efficiency. The Accipio suite included modules such as Accipio Ix for ICH identification and prioritization, Accipio Ax for image annotation, and Accipio Dxg for comprehensive ICH triage. MaxQ AI collaborated with major medical imaging original equipment manufacturers (OEMs) and partners, including Philips, GE Healthcare, Fujifilm, and IBM Watson Health, to integrate and distribute its solutions into existing radiology networks and PACS systems.
However, as of early 2022, MaxQ AI ceased commercial operations related to its Accipio line of software and discontinued its involvement in image analysis-based AI applications. The company announced a strategic pivot towards developing non-image-based AI algorithms for enterprise solutions, moving beyond the radiology department. More recent information from April 2026 indicates that MaxQ AI is considered a “deadpooled company,” suggesting it is no longer actively operating in the healthcare AI space.
Focus Areas
Business Intelligence
| Key Investors | Genesis Capital Advisors, Exigent Capital Group, Europa |
| Partnerships | GE Healthcare, IBM Watson, Samsung, Philips, Fujifilm Medical Systems USA, Blackford Analysis, Arterys, EnvoyAI (TeraRecon) (Note: These partnerships were for the discontinued Accipio platform) |
| Acquisitions | Ceased to operate; not acquired by another company. |
| Technology | Deep learning, machine vision, AI-powered Accipio platform for non-contrast head CT images; utilized Intel AI technologies (Intel Xeon, Intel Core CPUs, Intel Movidius VPUs, OpenVINO toolkit) (historical); shifted to non-image-based AI algorithms (post-pivot) |
| FDA Clearances | 1 cleared products (estimated) |
What Physicians Need to Know
MaxQ AI's Accipio platform was designed to seamlessly integrate into existing clinical workflows, providing rapid, AI-powered insights directly within CT and PACS systems. Physicians could benefit from automated identification and prioritization of suspected intracranial hemorrhages, allowing for quicker assessment and more informed decision-making in acute stroke and head trauma cases. The Accipio Ax's SliceMap feature, for instance, guided clinicians directly to relevant CT slices, streamlining image review. This 'augmented intelligence' approach aimed to enhance, not replace, the physician's expertise, leading to improved patient care and potentially reduced healthcare costs.
MaxQ AI had extensive partnerships with major medical imaging original equipment manufacturers (OEMs) and Picture Archiving and Communication Systems (PACS) providers. Their Accipio platform was integrated with solutions from GE Healthcare (via Edison Open AI Orchestrator), Philips CT systems, Samsung NeuroLogica (for mobile stroke units), Fujifilm (Synapse PACS), Arterys Marketplace, TeraRecon's EnvoyAI Exchange, and Blackford Analysis platforms. This broad integration strategy aimed to ensure their AI solutions were readily accessible within diverse acute care environments.
Reviews & Opinions
Videos
News, demos, and interviews about MaxQ AI.
Videos load interactively. If none appear, search YouTube for MaxQ AI →
Press & Coverage
Frequently Asked Questions
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]